{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T01:32:38Z","timestamp":1792287158282,"version":"4.4.0"},"reference-count":31,"publisher":"Cambridge University Press (CUP)","issue":"1","license":[{"start":{"date-parts":[[2019,10,29]],"date-time":"2019-10-29T00:00:00Z","timestamp":1572307200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Psychol. Med."],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec id=\"S0033291719003040_sec_a1\"><jats:title>Background<\/jats:title><jats:p>Early detection and intervention strategies in patients at clinical high-risk (CHR) for syndromal psychosis have the potential to contain the morbidity of schizophrenia and similar conditions. However, research criteria that have relied on severity and number of positive symptoms are limited in their specificity and risk high false-positive rates. Our objective was to examine the degree to which measures of recency of onset or intensification of positive symptoms [a.k.a., new or worsening (NOW) symptoms] contribute to predictive capacity.<\/jats:p><\/jats:sec><jats:sec id=\"S0033291719003040_sec_a2\" sec-type=\"methods\"><jats:title>Methods<\/jats:title><jats:p>We recruited 109 help-seeking individuals whose symptoms met criteria for the Progression Subtype of the Attenuated Positive Symptom Psychosis-Risk Syndrome defined by the Structured Interview for Psychosis-Risk Syndromes and followed every three months for two years or onset of syndromal psychosis.<\/jats:p><\/jats:sec><jats:sec id=\"S0033291719003040_sec_a3\" sec-type=\"results\"><jats:title>Results<\/jats:title><jats:p>Forty-one (40.6%) of 101 participants meeting CHR criteria developed a syndromal psychotic disorder [mostly (80.5%) schizophrenia] with half converting within 142 days (interquartile range: 69\u2013410 days). Patients with more NOW symptoms were more likely to convert (converters: 3.63 \u00b1 0.89; non-converters: 2.90 \u00b1 1.27; <jats:italic>p<\/jats:italic> = 0.001). Patients with stable attenuated positive symptoms were <jats:italic>less<\/jats:italic> likely to convert than those with NOW symptoms. New, but not worsening, symptoms, in isolation, also predicted conversion.<\/jats:p><\/jats:sec><jats:sec id=\"S0033291719003040_sec_a4\" sec-type=\"conclusions\"><jats:title>Conclusions<\/jats:title><jats:p>Results suggest that the severity and number of attenuated positive symptoms are less predictive of conversion to syndromal psychosis than the timing of their emergence and intensification. These findings also suggest that the earliest phase of psychotic illness involves a rapid, dynamic process, beginning before the syndromal first episode, with potentially substantial implications for CHR research and understanding the neurobiology of psychosis.<\/jats:p><\/jats:sec>","DOI":"10.1017\/s0033291719003040","type":"journal-article","created":{"date-parts":[[2019,10,29]],"date-time":"2019-10-29T07:19:51Z","timestamp":1572333591000},"page":"112-120","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":3,"title":["Recency and intensification of positive symptoms enhance prediction of conversion to syndromal psychosis in clinical high-risk patients"],"prefix":"10.1017","volume":"51","author":[{"given":"Gary","family":"Brucato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"First","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella A.","family":"Dishy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shana S.","family":"Samuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie M.","family":"Wall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A.","family":"Small","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Masucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Lieberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5715-8982","authenticated-orcid":false,"given":"Ragy R.","family":"Girgis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2019,10,29]]},"reference":[{"key":"S0033291719003040_ref2","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2013"},{"key":"S0033291719003040_ref21","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1176\/appi.ajp.159.5.863","article-title":"Prospective diagnosis of the prodrome for schizophrenia: preliminary evidence of interrater reliability and predictive validity using operational criteria and a structured interview","volume":"159","author":"Miller","year":"2002","journal-title":"American Journal of Psychiatry"},{"key":"S0033291719003040_ref5","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1017\/S003329171800171X","article-title":"A predictive model for conversion to psychosis in clinical high-risk patients","volume":"49","author":"Ciarleglio","year":"2019","journal-title":"Psychoogicall Medicine"},{"key":"S0033291719003040_ref18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/978-94-010-0892-1_7","volume-title":"Early Intervention in Psychotic Disorders","author":"McGlashan","year":"2001"},{"key":"S0033291719003040_ref14","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0920-9964(03)00053-7","article-title":"Factorial structure of the scale of prodromal symptoms","volume":"68","author":"Hawkins","year":"2004","journal-title":"Schizophrenia Research"},{"key":"S0033291719003040_ref17","doi-asserted-by":"crossref","first-page":"13S","DOI":"10.1016\/0893-133X(95)00200-W","article-title":"Psychobiologic correlates of treatment response in schizophrenia","volume":"14","author":"Lieberman","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"S0033291719003040_ref8","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1469-7610.2010.02235.x","article-title":"Research in people with the psychosis risk syndrome: a review of the current evidence and future directions","volume":"51","author":"Correll","year":"2010","journal-title":"Journal of Child Psychology and Psychiatry"},{"key":"S0033291719003040_ref26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.schres.2015.09.008","article-title":"Severity of thought disorder predicts psychosis in persons at clinical high-risk","volume":"169","author":"Perkins","year":"2015","journal-title":"Schizophrenia Research"},{"key":"S0033291719003040_ref1","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/NMD.0000000000000290","article-title":"North American prodrome Longitudinal Study (NAPLS-2): the prodromal symptoms","volume":"203","author":"Addington","year":"2015","journal-title":"The Journal of Nervous and Mental Disease"},{"key":"S0033291719003040_ref28","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1093\/schbul\/sbt171","article-title":"Prevalence and clinical significance of DSM-5-attenuated psychosis syndrome in adolescents and young adults in the general population: the Bern Epidemiological At-Risk (BEAR) study","volume":"40","author":"Schultze-Lutter","year":"2014","journal-title":"Schizophrenia Bulletin"},{"key":"S0033291719003040_ref11","volume-title":"Structured Clinical Interview for DSM-5 Disorders, Clinical Trials Version (SCID-5-CT)","author":"First","year":"2015"},{"key":"S0033291719003040_ref29","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/schbul\/17.2.325","article-title":"Neuroleptics and the natural course of schizophrenia","volume":"17","author":"Wyatt","year":"1991","journal-title":"Schizophrenia Bulletin"},{"key":"S0033291719003040_ref31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0920-9964(02)00167-6","article-title":"Psychosis prediction: 12-month follow up of a high-risk (\u201cprodromal\u201d) group","volume":"60","author":"Yung","year":"2003","journal-title":"Schizophrenia Research"},{"key":"S0033291719003040_ref4","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1176\/appi.ajp.2016.15070890","article-title":"An individualized risk calculator for research in prodromal psychosis","volume":"173","author":"Cannon","year":"2016","journal-title":"American Journal of Psychiatry"},{"key":"S0033291719003040_ref3","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1017\/S0033291717000319","article-title":"Baseline demographics, clinical features and predictors of conversion among 200 individuals in a longitudinal prospective psychosis-risk cohort","volume":"47","author":"Brucato","year":"2017","journal-title":"Psychological Medicine"},{"key":"S0033291719003040_ref27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00005053-200203000-00001","article-title":"Prospective observations of emerging psychosis","volume":"190","author":"Rosen","year":"2002","journal-title":"Journal of Nervous and Mental Disease"},{"key":"S0033291719003040_ref12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1001\/jamapsychiatry.2013.269","article-title":"The psychosis high-risk state: a comprehensive state-of-the-art review","volume":"70","author":"Fusar-Poli","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"S0033291719003040_ref25","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1176\/appi.ajp.162.10.1785","article-title":"Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis","volume":"162","author":"Perkins","year":"2005","journal-title":"American Journal of Psychiatry"},{"key":"S0033291719003040_ref20","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1023\/A:1022034115078","article-title":"Symptom assessment in schizophrenic prodromal states","volume":"70","author":"Miller","year":"1999","journal-title":"Psychiatric Quarterly"},{"key":"S0033291719003040_ref23","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/oxfordjournals.schbul.a007040","article-title":"Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability","volume":"29","author":"Miller","year":"2003","journal-title":"Schizophrenia Bulletin"},{"key":"S0033291719003040_ref13","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1001\/jamapsychiatry.2017.0284","article-title":"Development and validation of a clinically based risk calculator for the transdiagnostic prediction of psychosis","volume":"74","author":"Fusar-Poli","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"S0033291719003040_ref24","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/archpsyc.1994.03950110009002","article-title":"Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH genetics initiative","volume":"51","author":"Nurnberger","year":"1994","journal-title":"Archives of General Psychiatry"},{"key":"S0033291719003040_ref7","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1176\/appi.ajp.2015.13121686","article-title":"Psychosis prevention: a modified clinical high risk perspective from the recognition and prevention (RAP) program","volume":"172","author":"Cornblatt","year":"2015","journal-title":"American Journal of Psychiatry"},{"key":"S0033291719003040_ref30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.schres.2015.08.004","article-title":"Stigma related to labels and symptoms in individuals at clinical high-risk for psychosis","volume":"168","author":"Yang","year":"2015","journal-title":"Schizophrenia Research"},{"key":"S0033291719003040_ref16","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1001\/jamapsychiatry.2016.3055","article-title":"Distinct relationships between visual and auditory perceptual abnormalities and conversion to psychosis in a clinical high-risk population","volume":"74","author":"Lehembre-Shiah","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"S0033291719003040_ref15","unstructured":"IBM Corporation (2013) IBM SPSS Statistics for Windows, Version 22.0. IBM Corporation Armonk, NY."},{"key":"S0033291719003040_ref9","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1111\/eip.12529","article-title":"Attenuated first-rank symptoms and conversion to psychosis in a clinical high-risk cohort","volume":"12","author":"Crump","year":"2018","journal-title":"Early Intervention in Psychiatry"},{"key":"S0033291719003040_ref32","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/schbul\/sbm015","article-title":"Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk?","volume":"33","author":"Yung","year":"2007","journal-title":"Schizophrenia Bulletin"},{"key":"S0033291719003040_ref6","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1093\/schbul\/sbm029","article-title":"Preliminary findings for two new measures of social and role functioning in the prodromal phase of schizophrenia","volume":"33","author":"Cornblatt","year":"2007","journal-title":"Schizophrenia Bulletin"},{"key":"S0033291719003040_ref19","unstructured":"McGlashan, TH , Walsh, BC and Woods, SW (2014) Structured interview for psychosis-risk syndromes, English language (version 5.6) PRIME Research Clinic, Yale School of Medicine: New Haven, CT."},{"key":"S0033291719003040_ref10","volume-title":"Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV)","author":"First","year":"1996"}],"container-title":["Psychological Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0033291719003040","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T12:21:31Z","timestamp":1612182091000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0033291719003040\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,29]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0033291719003040"],"URL":"https:\/\/doi.org\/10.1017\/s0033291719003040","relation":{},"ISSN":["0033-2917","1469-8978"],"issn-type":[{"value":"0033-2917","type":"print"},{"value":"1469-8978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,29]]},"assertion":[{"value":"Copyright \u00a9 Cambridge University Press 2019","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}]}}